{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:04:53Z","timestamp":1788375893056,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003142","name":"Fonds NutsOhra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003142","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ajog.2014.03.032","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T06:32:00Z","timestamp":1395210720000},"page":"373.e1-373.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Systematic review and metaanalysis on nonclassic cardiovascular biomarkers after hypertensive pregnancy disorders"],"prefix":"10.1016","volume":"211","author":[{"given":"Sanne","family":"Visser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wietske","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.F.","family":"Ket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 H.J.","family":"Otten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"van Pampus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitty W.M.","family":"Bloemenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Franx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben W.","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne J.M.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2014.03.032_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1207\/S15327558IJBM0903_05","article-title":"Women's hearts need special treatment","volume":"9","author":"Burell","year":"2002","journal-title":"Int J Behav Med"},{"key":"10.1016\/j.ajog.2014.03.032_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/eurheartj\/ehi819","article-title":"Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology","volume":"27","author":"Stramba-Badiale","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajog.2014.03.032_bib3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJM199605163342007","article-title":"The evaluation of chest pain in women","volume":"334","author":"Douglas","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.03.032_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvq394","article-title":"Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology","volume":"90","author":"Vaccarino","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajog.2014.03.032_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.308.6933.883","article-title":"Chest pain in women: clinical, investigative, and prognostic features","volume":"308","author":"Sullivan","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2014.03.032_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1552-6909.2011.01234.x","article-title":"Women's risk factors and screening for coronary heart disease","volume":"40","author":"Arslanian-Engoren","year":"2011","journal-title":"J\u00a0Obstet Gynecol Neonatal Nurs"},{"key":"10.1016\/j.ajog.2014.03.032_bib7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/1471-0528.12191","article-title":"Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature-based study","volume":"120","author":"Berks","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2014.03.032_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.325.7356.157","article-title":"Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?","volume":"325","author":"Sattar","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2014.03.032_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/humupd\/dms060","article-title":"Genetic variants in pre-eclampsia: a meta-analysis","volume":"19","author":"Buurma","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2014.03.032_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/OGX.0b013e31827682fc","article-title":"Biochemical cardiovascular risk factors after hypertensive pregnancy disorders: a systematic review and meta-analysis","volume":"67","author":"Hermes","year":"2012","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajog.2014.03.032_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2796.2012.02589.x","article-title":"Identifying novel biomarkers for cardiovascular disease risk prediction","volume":"272","author":"Ge","year":"2012","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ajog.2014.03.032_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1373\/clinchem.2011.165712","article-title":"Biomarkers and cardiovascular risk assessment for primary prevention: an update","volume":"58","author":"Gilstrap","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2014.03.032_bib13","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.2174\/138161208785777388","article-title":"Candidate circulating biomarkers for the cardiovascular disease continuum","volume":"14","author":"Dotsenko","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajog.2014.03.032_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/01443615.2012.709290","article-title":"Biomarkers in pre-eclampsia: a novel approach to early detection of the disease","volume":"32","author":"Masoura","year":"2012","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2014.03.032_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mam.2007.04.002","article-title":"Serum markers for predicting pre-eclampsia","volume":"28","author":"Baumann","year":"2007","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ajog.2014.03.032_bib16","doi-asserted-by":"crossref","first-page":"IX","DOI":"10.3109\/10641950109152635","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2014.03.032_bib17","first-page":"181","article-title":"Diagnosis and management of gestational hypertension and preeclampsia","volume":"102","author":"Sibai","year":"2003","journal-title":"Obstet and Gynecol"},{"key":"10.1016\/j.ajog.2014.03.032_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2014.03.032_bib19","first-page":"941","article-title":"Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia","volume":"84","author":"Deng","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.03.032_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000292029","article-title":"Hemostatic abnormalities may predict chronic hypertension after preeclampsia","volume":"41","author":"Bremme","year":"1996","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2014.03.032_bib21","first-page":"344","article-title":"Evidence of high circulating testosterone in women with prior preeclampsia","volume":"83","author":"Laivuori","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2014.03.032_bib22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00004872-199917090-00011","article-title":"Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia?","volume":"17","author":"Barden","year":"1999","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ajog.2014.03.032_bib23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0037-1614520","article-title":"Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia","volume":"81","author":"He","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2014.03.032_bib24","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/jama.285.12.1607","article-title":"Association of maternal endothelial dysfunction with preeclampsia","volume":"285","author":"Chambers","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2014.03.032_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.HYP.0000074428.11168.EE","article-title":"Classic and novel risk factor parameters in women with a history of preeclampsia","volume":"42","author":"Sattar","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2014.03.032_bib26","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1160\/TH03-01-0053","article-title":"Markers of endothelial activation and atherothrombosis in women with history of preeclampsia or gestational hypertension","volume":"90","author":"Vickers","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2014.03.032_bib27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/01.HYP.0000143849.67254.ca","article-title":"Short- and long-term changes in plasma inflammatory markers associated with preeclampsia","volume":"44","author":"Freeman","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2014.03.032_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1471-0528.2004.00051.x","article-title":"Thiol status and antioxidant capacity in women with a history of severe pre-eclampsia","volume":"111","author":"Raijmakers","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2014.03.032_bib29","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1210\/jc.2004-0548","article-title":"Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance","volume":"89","author":"Wolf","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2014.03.032_bib30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jc.2005-1337","article-title":"Cardiovascular risk factors in healthy women with previous gestational hypertension","volume":"91","author":"Paradisi","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2014.03.032_bib31","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.107.087528","article-title":"Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance","volume":"49","author":"Girouard","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2014.03.032_bib32","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/HJH.0b013e3282ef5fc0","article-title":"Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy","volume":"25","author":"Hamad","year":"2007","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ajog.2014.03.032_bib33","doi-asserted-by":"crossref","first-page":"e1865","DOI":"10.1371\/journal.pone.0001865","article-title":"Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome","volume":"3","author":"van Rijn","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2014.03.032_bib34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/HYPERTENSIONAHA.108.113423","article-title":"A\u00a0relationship between insulin sensitivity and vasodilation in women with a history of preeclamptic pregnancy","volume":"52","author":"Lampinen","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2014.03.032_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2008.10.005","article-title":"Haemostatic factors in women with history of preeclampsia","volume":"124","author":"Portelinha","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2014.03.032_bib36","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/00016340802322265","article-title":"Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with history of preeclampsia","volume":"87","author":"Portelinha","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2014.03.032_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10641955.2010.484085","article-title":"Skin autofluorescence as marker of tissue advanced glycation end-products accumulation in formerly preeclamptic women","volume":"30","author":"Coffeng","year":"2011","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2014.03.032_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.regpep.2011.03.005","article-title":"Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy","volume":"168","author":"Stepan","year":"2011","journal-title":"Regul Pept"},{"key":"10.1016\/j.ajog.2014.03.032_bib39","doi-asserted-by":"crossref","first-page":"e43637","DOI":"10.1371\/journal.pone.0043637","article-title":"Angiogenic factors in women ten years after severe very early onset preeclampsia","volume":"7","author":"Gaugler-Senden","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl 4","key":"10.1016\/j.ajog.2014.03.032_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1520-037X.2007.07255.x","article-title":"Guidelines for prevention of cardiovascular disease in women: a summary of recommendations","volume":"10","author":"Mosca","year":"2007","journal-title":"Prev Cardiol"},{"key":"10.1016\/j.ajog.2014.03.032_bib41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12529-012-9242-5","volume":"19","author":"Perk","year":"2012","journal-title":"Int J Behav Med"},{"key":"10.1016\/j.ajog.2014.03.032_bib42","first-page":"CD006612","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","volume":"1","author":"Mart\u00ed-Carvajal","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2014.03.032_bib43","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/oxfordjournals.aje.a009400","article-title":"Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study","volume":"147","author":"Ros","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2014.03.032_bib44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","article-title":"A\u00a0critical review of early-onset and late-onset preeclampsia","volume":"66","author":"Raymond","year":"2011","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajog.2014.03.032_bib45","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1515\/cclm-2011-0856","article-title":"Plasma total homocysteine is\u00a0a determinant of carotid intima-media thickness and circulating endothelial progenitor cells in patients with newly diagnosed hypertension","volume":"50","author":"Bogdanski","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ajog.2014.03.032_bib46","doi-asserted-by":"crossref","first-page":"a3083","DOI":"10.1136\/bmj.a3083","article-title":"Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study","volume":"338","author":"Ruijter","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2014.03.032_bib47","doi-asserted-by":"crossref","unstructured":"Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288:2015-22.","DOI":"10.1001\/jama.288.16.2015"},{"key":"10.1016\/j.ajog.2014.03.032_bib48","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/01443615.2012.693985","article-title":"The role of homocysteine, asymmetric dimethylarginine and nitric oxide in pre-eclampsia","volume":"32","author":"Demir","year":"2012","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2014.03.032_bib49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/01443615.2012.709290","article-title":"Biomarkers in pre-eclampsia: a novel approach to early detection of the disease","volume":"32","author":"Masoura","year":"2012","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2014.03.032_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10545-010-9151-1","article-title":"The homocysteine controversy","volume":"34","author":"Smulders","year":"2011","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.ajog.2014.03.032_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2013.01.019","article-title":"Clinical correlates of change in inflammatory biomarkers: the Framingham Heart Study","volume":"228","author":"Fontes","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajog.2014.03.032_bib52","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1515\/cclm.2011.820","article-title":"Candidate biochemical markers for screening of pre-eclampsia in early pregnancy","volume":"50","author":"Forest","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ajog.2014.03.032_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1179\/1607845412Y.0000000070","article-title":"Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia","volume":"18","author":"Aref","year":"2013","journal-title":"Hematology"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814002427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814002427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:58:40Z","timestamp":1757588320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937814002427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0002937814002427"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2014.03.032","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review and metaanalysis on nonclassic cardiovascular biomarkers after hypertensive pregnancy disorders","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2014.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}